1.
Kugler E. Charting a path through resistance: histone deacetylase inhibitors for TP53-mutated B-cell acute lymphoblastic leukemia. Haematologica 2024; 109(6):1643-1645; https://doi.org/10.3324/haematol.2023.284796.